Immunohistochemical analysis of 147 cases of low-grade endometrial stromal sarcoma: refining the immunohistochemical profile of LG-ESS on a large, molecularly confirmed series
Miroslava Flídrová(Charles University), Ihor Varchak(Khmelnytskyi National University), Tetiana Piatnytska(Khmelnytskyi National University), Ròbert Póka(Gynecologic Oncology Group), Francesca Ciccarone(Agostino Gemelli University Polyclinic), Jitka Hausnerová(Masaryk University), Simona Stolnicu(Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș), Ignacio Zapardiel(Hospital Universitario La Paz), Renata Poncová(Charles University), Zuzana Špůrková(Fakultní nemocnice Bulovka), Ján Laco(Charles University), Giovanni Scambia(Agostino Gemelli University Polyclinic), Milan Krkoška, Archil Sharashenidze(Caucasus University), Magdalena Bizoń, Alberto Berjón(Hospital Universitario La Paz), J Bouda(Charles University), Květoslava Michalová(Charles University), Georgína Kolníková(National Institute of Cardiovascular Diseases), Włodzimierz Sawicki(Medical University of Warsaw), Mariusz Książek(National Institute of Oncology), Marta Ostrowska-Leśko(Medical University of Lublin), Radovan Pilka(University Hospital Olomouc), Dagmar Dolínská, Nataliya Volodko(Danylo Halytsky Lviv National Medical University), Marcin Bobiński(Medical University of Lublin), Michael J. Halaška(Charles University), Jaroslav Klát(University Hospital Ostrava), Radim Marek(University Hospital Olomouc), Maciej Stukan(Gdańsk Medical University), Iryna Yezhova(Lviv National Musical Academy named after Mykola Lysenko), Michal Zikán(Charles University), David Cibula(Charles University), Ivan Franin(University Hospital Centre Zagreb), Pavel Dundr(Charles University), Tymoteusz Poprawski(Lublin Oncology Center), Vladimír Židlík(University Hospital Ostrava), Marcin Jędryka(Lublin Oncology Center), Vladimír Kalist(Tomas Bata University in Zlín), Miranda Gudadze(Caucasus University), Petra Bretová(Masaryk University), Mihai Emil Căpîlna(Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș), Zoárd Tibor Krasznai(University of Debrecen), Jana Drozenová(Charles University), Munachiso Ndukwe(Charles University), Antonela Njavro(University Hospital Centre Zagreb), Romana Vránková(Charles University), Karolina Grabowska(Pomeranian Medical University), Janusz Ryś(The Maria Sklodowska-Curie National Research Institute of Oncology), Kristýna Němejcová(Charles University)
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
January 21, 2025
Cited by 4
Related Papers
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
|New England Journal of Medicine|2018|2.9k
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2017|1.9k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
|Annals of Oncology|2019|1.2k
Proteogenomic Characterization of Endometrial Carcinoma
|Cell|2020|534